সংবাদ

Ripple CEO Brad Garlinghouse will address the Senate on the need for crypto market legislation and regulatory clarity in the ...
Ripple CEO Brad Garlinghouse clarified that Linqto acquired 4.7 million Ripple shares entirely via secondary markets and not ...
In stunning XRP news, Ripple's Brad Garlinghouse says his XRP tattoo signals a 1,000% commitment to the project as its SEC ...
Can Dogecoin reclaim the key level of $0.25? Ripple CEO has confirmed the company is applying for a US banking license: ...
Ripple ends its legal fight with the SEC as XRP jumps over 3 percent following CEO Brad Garlinghouse's announcement.
Ripple CEO Brad Garlinghouse clarified that Ripple never sold shares directly to Linqto amid ongoing federal investigations ...
Ripple CEO Brad Garlinghouse shows a strong commitment to XRP with a new tattoo symbolizing his “1,000%” dedication.
When Ripple CEO Brad Garlinghouse first joined Ripple Labs in 2015, he probably didn’t expect to become a central figure in one of cryptocurrency’s biggest legal battles. Aside from sparring with ...
Ripple CEO Brad Garlinghouse is predicting crypto adoption will soar this year as US President Donald Trump embraces the industry. In a new interview with Fox Business, Garlinghouse says that since ...
Ripple Labs’ newest stablecoin product has received final approval from a prominent New York regulator. In a post on the social media platform X, Ripple chief executive Brad Garlinghouse says that ...
MSN-এ হোস্ট করা হয়েছে19দিন
Ripple CEO Brad Garlinghouse says Bitcoin is not the enemy
CEO of Ripple Labs, Brad Garlinghouse, surprised the entire XRP community and much of the wider crypto community when he said, “Bitcoin is not the enemy,” at the XRP Las Vegas 2025 conference.
MSN-এ হোস্ট করা হয়েছে6সোম
Ripple’s CEO Brad Garlinghouse meets with Donald Trump at Mar-a-Lago - MSN
President-elect Donald Trump met with Ripple’s CEO Brad Garlinghouse at his Mar-a-Lago estate in Florida on 8th January. The two were also joined by Ripple’s Chief Legal Officer Stuart Alderoty.